Literature DB >> 9788969

Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.

M M Véniant1, C H Zlot, R L Walzem, V Pierotti, R Driscoll, D Dichek, J Herz, S G Young.   

Abstract

The role of the low density lipoprotein receptor (LDLR) in the clearance of apo-B48-containing lipoproteins and the role of the LDLR-related protein (LRP) in the removal of apo-B100-containing lipoproteins have not been clearly defined. To address these issues, we characterized LDLR-deficient mice homozygous for an "apo-B48-only" allele, an "apo-B100-only" allele, or a wild-type apo-B allele (Ldlr-/- Apob48/48, Ldlr-/-Apob100/100, and Ldlr-/-Apob+/+, respectively). The plasma apo-B48 and LDL cholesterol levels were higher in Ldlr-/-Apob48/48 mice than in Apob48/48 mice, indicating that the LDL receptor plays a significant role in the removal of apo-B48-containing lipoproteins. To examine the role of the LRP in the clearance of apo-B100-containing lipoproteins, we blocked hepatic LRP function in Ldlr-/-Apob100/100 mice by adenoviral-mediated expression of the receptor-associated protein (RAP). RAP expression did not change apo-B100 levels in Ldlr-/-Apob100/100 mice. In contrast, RAP expression caused a striking increase in plasma apo-B48 levels in Apob48/48 and Ldlr-/-Apob48/48 mice. These data imply that LRP is important for the clearance of apo-B48-containing lipoproteins but plays no significant role in the clearance of apo-B100-containing lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788969      PMCID: PMC509006          DOI: 10.1172/JCI4164

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.

Authors:  M M Véniant; V Pierotti; D Newland; C M Cham; D A Sanan; R L Walzem; S G Young
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 2.  Genetically modified mice for the study of apolipoprotein B.

Authors:  E Kim; S G Young
Journal:  J Lipid Res       Date:  1998-04       Impact factor: 5.922

Review 3.  Receptor-associated protein: a specialized chaperone and antagonist for members of the LDL receptor gene family.

Authors:  G Bu
Journal:  Curr Opin Lipidol       Date:  1998-04       Impact factor: 4.776

4.  Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.

Authors:  M F Linton; A H Hasty; V R Babaev; S Fazio
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

5.  Dual mechanisms for the low plasma levels of truncated apolipoprotein B proteins in familial hypobetalipoproteinemia. Analysis of a new mouse model with a nonsense mutation in the Apob gene.

Authors:  E Kim; C M Cham; M M Véniant; P Ambroziak; S G Young
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

6.  Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.

Authors:  R W Milne; P K Weech; L Blanchette; J Davignon; P Alaupovic; Y L Marcel
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

7.  The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein.

Authors:  U Beisiegel; W Weber; G Ihrke; J Herz; K K Stanley
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

8.  Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins.

Authors:  R C Kowal; J Herz; J L Goldstein; V Esser; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

Review 9.  Recent progress in understanding apolipoprotein B.

Authors:  S G Young
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

10.  Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes.

Authors:  M Raabe; L M Flynn; C H Zlot; J S Wong; M M Véniant; R L Hamilton; S G Young
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more
  40 in total

1.  Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice.

Authors:  M Raabe; M M Véniant; M A Sullivan; C H Zlot; J Björkegren; L B Nielsen; J S Wong; R L Hamilton; S G Young
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  68Ga-DOTA-RGD peptide: biodistribution and binding into atherosclerotic plaques in mice.

Authors:  Seppo Ylä-Herttula; Juhani Knuuti; Anne Roivainen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

3.  LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis.

Authors:  John T Melchior; Janet K Sawyer; Kathryn L Kelley; Ramesh Shah; Martha D Wilson; Roy R Hantgan; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2013-06-26       Impact factor: 5.922

4.  ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.

Authors:  Philip L S M Gordts; Ryan Nock; Ni-Huiping Son; Bastian Ramms; Irene Lew; Jon C Gonzales; Bryan E Thacker; Debapriya Basu; Richard G Lee; Adam E Mullick; Mark J Graham; Ira J Goldberg; Rosanne M Crooke; Joseph L Witztum; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2016-07-11       Impact factor: 14.808

5.  The role of the LDL receptor in apolipoprotein B secretion.

Authors:  J Twisk; D L Gillian-Daniel; A Tebon; L Wang; P H Barrett; A D Attie
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

6.  Giardia lamblia low-density lipoprotein receptor-related protein is involved in selective lipoprotein endocytosis and parasite replication.

Authors:  Maria R Rivero; Silvana L Miras; Rodrigo Quiroga; Andrea S Rópolo; Maria C Touz
Journal:  Mol Microbiol       Date:  2011-01-05       Impact factor: 3.501

Review 7.  Animal models of atherosclerosis.

Authors:  Fatemeh Ramezani Kapourchali; Gangadaran Surendiran; Li Chen; Elisabeth Uitz; Babak Bahadori; Mohammed H Moghadasian
Journal:  World J Clin Cases       Date:  2014-05-16       Impact factor: 1.337

8.  Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.

Authors:  Pei Yu; Ting Xiong; Christine B Tenedero; Paul Lebeau; Ran Ni; Melissa E MacDonald; Peter L Gross; Richard C Austin; Bernardo L Trigatti
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-21       Impact factor: 8.311

9.  Apo E structure determines VLDL clearance and atherosclerosis risk in mice.

Authors:  C Knouff; M E Hinsdale; H Mezdour; M K Altenburg; M Watanabe; S H Quarfordt; P M Sullivan; N Maeda
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

10.  K Domain CR9 of Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1) Is Critical for Aggregated LDL-induced Foam Cell Formation from Human Vascular Smooth Muscle Cells.

Authors:  Paula Costales; Pablo Fuentes-Prior; Jose Castellano; Elena Revuelta-Lopez; Maria Ángeles Corral-Rodríguez; Laura Nasarre; Lina Badimon; Vicenta Llorente-Cortes
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.